Results 131 to 140 of about 44,633 (211)

Neurologic Stability During Tafamidis Treatment in Transthyretin Amyloidosis with a Mixed Phenotype: A Multicenter Real-World Study. [PDF]

Cardiol Ther
Fine NM, Streicher NS, Conceição I, Agostinho J, Obici L, Palladini G, Carlsson M, Amass L, Sheikh FH.   +8 more
europepmc   +1 more source

Case Report: Inotersen reintroduction after thrombocytopenia in hereditary transthyretin amyloidosis: a case series. [PDF]

Front Pharmacol
Crespi CA, Zanga G, Ardanaz MF, Chinigo MP, Bianco G, Ibañez Aldecoa ADM.   +5 more
europepmc   +1 more source

INSIGHT Model: Explainable Artificial Intelligence for Real-World EHR-Based Screening of Transthyretin Amyloidosis Cardiomyopathy. [PDF]

JACC Adv
Arora A, Khan MS, Sunderman C, Baldwin N, Bennett M, Bomar VA, Cross L, da Graca B, Ettlinger J, Gottlieb RL, Hammonds K, Mack M, Masri A, Papas M, Priest EL, Shaver C, Venditto J, Butler J.   +17 more
europepmc   +1 more source

Central nervous system manifestations in hereditary transthyretin amyloidosis: a cross-sectional study with 151 patients. [PDF]

J Neurol
Sousa L, Coelho T, Fernandes J, Cardoso M, Alves C, da Silva AM, Sousa AP, Pinto MM, Pereira RM, Ruano L, Lemos C, Baldeiras I, Reis C, Taipa R.   +13 more
europepmc   +1 more source

Cascade genetic screening in families with hereditary transthyretin amyloidosis: diagnostic and prognostic impact. [PDF]

Eur Heart J
Cappelli F, Fumagalli C, Luigetti M, Mussinelli R, Longhi S, Guaraldi P, Aimo A, Argirò A, Barilaro A, Biagini E, Biagioni G, Ceccanti M, Cipriani A, Chimenti C, De Michieli L, Di Bella G, Emdin M, Graziani F, Imazio M, Limongelli G, Lofiego C, Musca F, Ossola P, Nuvolone M, Perlini S, Pieroni M, Porcari A, Musumeci B, Palmiero G, Perfetto F, Ruotolo I, Russo M, Tini G, Vergaro G, Vagnarelli F, Verrillo F, Sciarrone MA, Salvalaggio A, Zampieri M, Mazzoni C, Sinagra G, Palladini G, Merlo M, Obici L.   +43 more
europepmc   +1 more source

Atypical Dilated and Nonhypertrophic Cardiac Transthyretin Amyloidosis: Concept of Overlapping Cardiomyopathies. [PDF]

CASE (Phila)
Simard L, Couture CY, Morin J, Bernier M, O'Connor K, Salaun E.   +5 more
europepmc   +1 more source

TTR Variant p.Ala65Val Causing Early-Onset Hereditary Transthyretin Amyloidosis With Mixed Cardiac and Neuropathic Phenotype. [PDF]

JACC Case Rep
Torres-Valencia J, Reyes-Villanes S, Quispe E, Purizaca-Rosillo N, Saavedra-Cordova L, Araujo-Chumacero MM, Román R, Espinoza F, Mamani JF, Reyes-Rocha M.   +9 more
europepmc   +1 more source

Vutrisiran for transthyretin amyloidosis. [PDF]

Aust Prescr
europepmc   +1 more source

A Network Meta-Analysis of Hereditary Transthyretin Amyloidosis With Polyneuropathy Supports a Class Effect, Not a Ranking of Individual Drugs. [PDF]

Eur J Neurol
Streicher N, Mezei M, Luigetti M.
europepmc   +1 more source